Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOCUS - Muscadine Grape Extract for Fatigue in Cancer Survivors
NCT04495751Phase 1Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Apr 2021
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in fatigue (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Patient Reported Outcomes Measurement System Fatigue 7a at 12 weeks. Started Apr 2021; status: completed.
02
Conditions
fatigue
Beyond the preview
Go deeper on NCT04495751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04495751.